Pharmaceutical
Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics-H-C-PSUSA-00010008/201410
Advanced pharmaceutical formulation for targeted therapeutic intervention.